PTGS2 and adenomyosis: Previous studies show that COX-2 is overexpressed in mesenchymal stem cells originating from the endometrium of adenomyosis lesions and normal uterus, and a COX-2 inhibitor can inhibit the invasion and metastasis of mesenchymal stem cells derived from adenomyosis and induce apoptosis (Chen et al., 2010).